Black Friday Sale: 20% off everything. Ends Tuesday 1 December, 11:59 pm AEDT.
For laboratory and research use only. Not for human consumption.  Sold exclusively to qualified researchers and licensed laboratories.

CATALOGUE  /  DSIP

DSIP 10MG

DSIP, lyophilised powder in a sealed vial

DSIP

Research peptide · Lyophilised powder in a sealed vial · for laboratory and research use only

DSIP 10mg Quantity per vial: 10mg
$69.99$55.99
Secure card payments
Not a drug, food or cosmetic. For laboratory and research use only. Not for human consumption. This product has not been evaluated or approved by the US Food and Drug Administration (FDA) or the Australian Therapeutic Goods Administration (TGA), and it is not intended to diagnose, treat, cure or prevent any disease. Sold exclusively to qualified researchers and licensed laboratories.

Reagent specifications

CAS number62568-57-4 (PubChem also lists 69431-45-4)
Molecular weight848.8 g/mol (PubChem reference value)
StorageSealed, dry and dark at −20 °C or colder; warm to room temperature in a desiccator before opening
Certificate of analysisAvailable on request · Request a COA

CAS number and molecular weight are reference values for the compound identity, from PubChem. Because two CAS numbers circulate, search databases and supplier documents under both.

Compound identity

Compound classLinear nonapeptide
Sequence (one-letter)WAGGDASGE
Sequence (three-letter)Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Molecular formulaC35H48N10O15 (PubChem)
PubChem CID68816
Other namesEmideltide (INN)
OriginIsolated from rabbit cerebral venous blood plasma, Basel, 1977
Supplied asLyophilised powder, sealed vial
Quantity per vial10 mg
Intended useLaboratory and research use only

About DSIP

DSIP is a linear nonapeptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE), with the international non-proprietary name emideltide.1 It was first isolated in 1977 by a group in Basel, Switzerland, from rabbit cerebral venous blood plasma.

Titan Peptides supplies DSIP as a lyophilised powder in a sealed 10 mg vial, for laboratory and research use only. It is a research chemical: not a drug, food or cosmetic, and not for human consumption.

Status in Australia

Australia's June 2026 Poisons Standard (F2026L00633) names neither DSIP nor emideltide.2 DSIP is not an approved therapeutic good in Australia, and the research-grade DSIP sold here is a laboratory chemical. Whether a product counts as a therapeutic good depends on its supply and presentation; see our guide to research peptides and Australian law.

Laboratory handling & storage

DSIP starts with a tryptophan, a residue vulnerable to oxidation and to photo-oxidation, and published stability data show that enzymes in biological fluids degrade it quickly, so handling conditions matter. Keep the sealed vial dry, dark and at −20 °C or colder, bring it to room temperature in a desiccator before opening, and close it quickly, ideally under nitrogen or argon. Make solutions under clean conditions, divide them into single-use aliquots and freeze them, avoiding repeated freeze–thaw. Confirm identity by mass spectrometry rather than immunoassay. More on storing lyophilised and reconstituted peptides and choosing a diluent for reconstitution.

DSIP quick answers

What form is DSIP supplied in?

DSIP is supplied as a lyophilised (freeze-dried) powder in a sealed vial containing 10 mg, for laboratory and research use only. It is a research chemical, not a drug, food or cosmetic, and is not for human consumption.

What is emideltide?

Emideltide is DSIP's international non-proprietary name (INN), the name used in regulatory and chemical databases. Search under both names to find the full chemical literature on the compound.

What is DSIP's CAS number?

PubChem gives DSIP the CAS number 62568-57-4 and also lists 69431-45-4. Its PubChem CID is 68816, its molecular formula C35H48N10O15 and its molar mass 848.8 g/mol. The one-letter sequence is WAGGDASGE. Because two CAS numbers circulate, search databases and supplier documents under both.

Is DSIP legal in Australia?

Neither DSIP nor emideltide is named in the June 2026 Poisons Standard. Labelling alone does not decide status: the Therapeutic Goods Act 1989 covers goods presented as, or likely to be taken as, being for therapeutic use. The DSIP sold here is not an approved therapeutic good and is for laboratory and research use only.

References

  1. PubChem. Emideltide (DSIP), CID 68816. National Center for Biotechnology Information. Source
  2. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 (Standard for the Uniform Scheduling of Medicines and Poisons No. 48), F2026L00633. Commenced 1 June 2026. Federal Register of Legislation. Source
Research use only. Not a drug, food or cosmetic. DSIP is supplied strictly for laboratory and in-vitro research and is not for human consumption. It is not an approved therapeutic good in Australia, has not been evaluated or approved by the FDA or the TGA, and is not intended to diagnose, treat, cure or prevent any disease. Titan Peptides sells exclusively to qualified researchers and licensed laboratories.